---
created: 2025-04-13
updated: 2025-04-13T10:53
id: m#Py.~tH7?
specialty: neuro
specialty_id: 296
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::15-neuro::07-other::08-parkinson‚äôs,-huntington‚äôs,-&-movement-disorders
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::08-parkinson-disease-therapy
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::08-parkinson-disease-therapy::treatment-of-extrapyramidal-symptoms
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::13-psychiatric::03-extrapyramidal-symptoms-(including-acute-dystonia)
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::14-neuro::12-dopamine-availability-(amantadine)
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::15-other-neuro::amantadine
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::15-other-neuro::benztropine,-trihexyphenidyl
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::06-neuro/psych::fa-neuro
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::200-299::261
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - "source/ak-step2-v11:": 
  - theme/b&b::03-psych::04-psychopharmacology::02-antipsychotics::02-typical-antipsychotics
  - "source/ak-step2-v11:": 
  - theme/b&b::04-neuro::03-movement-disorders::01-parkinson's-disease"
type: flashcard
---

# Question
What features of extrapyramidal symptoms may be treated with benztropine and amantadine?   **Parkinsonism**

---

# Answer
